PMID: 5171322Oct 1, 1971Paper

Impaired lymphocyte reactivity against tumour cells in patients with coeliac disease

Gut
B P MaclaurinN R Ling

Abstract

The lymphocytes of patients with coeliac disease are shown to have a significant diminution of proliferative and cytotoxic capacity as compared to normal lymphocytes when challenged in vitro with tumour cells from a lymphoma cell line. This impaired responsiveness is partly related to an intrinsic cellular defect but an inhibiting factor in the serum of coeliac patients has also been demonstrated. The impaired coeliac lymphocyte response in this in-vitro test system may serve as an indicator of a comparable defect in immune surveillance in vivo. This would account for the increased incidence of lymphosarcoma known to arise in patients with longstanding coeliac disease and might also explain the raised incidence of other gut-related tumours in these patients.

Citations

May 1, 1982·European Journal of Pediatrics·A AshkenaziN Barzilai
Sep 1, 1979·Digestive Diseases and Sciences·W S Selby, N D Gallagher
May 1, 1977·The British Journal of Dermatology·D J Gould, R Howell
Nov 1, 1972·Australian and New Zealand Journal of Medicine·B P MaclaurinJ A Kilpatrick
Nov 1, 1976·Gut·B B Scott, M S Losowsky
May 1, 1976·Gut·D P O'DonoghueP J Kumar
Nov 1, 1972·Postgraduate Medical Journal·S Kenwright
Nov 1, 1984·Postgraduate Medical Journal·M Shiner
Jan 1, 1981·Virchows Archiv. A, Pathological Anatomy and Histology·H F OttoJ O Gebbers
Dec 1, 1988·Tubercle·A J WilliamsD E Stableforth
Apr 1, 1987·Irish Journal of Medical Science·E G BreenC F McCarthy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.